about
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signalingIL-1β-dependent activation of dendritic epidermal T cells in contact hypersensitivity.IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas.Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells.NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity.Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.The effect of short-chain fatty acids on human monocyte-derived dendritic cellsMalignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaGamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Elucidating the role of interleukin-17F in cutaneous T-cell lymphomaEctopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.Investigating heredity in cutaneous T-cell lymphoma in a unique cohort of Danish twins.Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes.Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells.A novel BLK-induced tumor model.Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner.Vitamin D Counteracts Mycobacterium tuberculosis-Induced Cathelicidin Downregulation in Dendritic Cells and Allows Th1 Differentiation and IFNγ SecretionJak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaSTAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.Malignant T cells secrete galectins and induce epidermal hyperproliferation and disorganized stratification in a skin model of cutaneous T-cell lymphoma.Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogrammingVascular endothelial growth factor receptor-3 expression in mycosis fungoides.Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.STAT5 induces miR-21 expression in cutaneous T cell lymphoma.A novel xenograft model of cutaneous T-cell lymphoma.Deficient SOCS3 and SHP-1 expression in psoriatic T cells.Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells.FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.
P50
Q24629558-0B865F94-8C53-4E8B-BC2A-168122515E89Q28214491-20245533-CBD7-4A7C-9E6C-694C22F0EDFAQ33608549-D84BE67A-0728-4A51-BB5D-4A60C30CA108Q33728396-EF8D7333-D268-4802-88B4-5478E8C21793Q33987080-F1031E84-9D46-4405-87EB-E1AC8D1AC52CQ34154516-A1AB76CD-CCA7-4306-80DC-1D0DE339ACB9Q34635116-426EEFAA-A738-4EFA-900F-368F34C4DEA9Q35162343-9577FB41-F053-4550-89C4-C9D3500C138FQ35470503-5B45A734-B35B-45EB-9955-FEF983D18553Q35751101-98504137-B32B-4801-AA81-A60112730F1FQ35833770-7666D017-C694-49C4-B8A5-76F0E4CBFD3FQ36020985-4AAD88E7-9608-4C15-A1DF-404EF5159EC3Q36675064-A160818B-57BF-4265-81E0-B0C464A6C1DEQ36982497-E36C2225-61F8-4DC7-8FFE-423D3F026405Q37139517-30CB8D1C-72C7-4F65-BB79-EAAFDF9BB1BAQ37216178-2F825CFD-F5BE-40B4-88C6-A572A541B853Q37237464-139D9686-4FFE-4A28-B611-D3E2AF7D1A7EQ37634755-74694D53-F32F-42BB-B7B5-7CBC46161689Q37929548-6A769071-1FA4-4C11-91BD-1B0AC1B1CC27Q38311269-B5543829-20E3-494C-A4FC-5C9D67B73562Q38323614-6B65809F-638F-453A-8000-5CEFC70611D3Q38698300-B912AD25-2949-409B-8017-D2BF80F0EC0AQ38714687-FAB8FE0C-E26F-45CE-B7B0-8E98CB6F6C1FQ38723153-9BE44B37-4E9B-4D54-81FF-C4870BBDF970Q38846167-23E84C27-52F5-456D-9016-F01F55881F90Q38951439-C97A0CC6-A6BE-4A03-95EF-42A2DE12C4E0Q38976959-AF8B12CE-67D6-4771-8E73-8383A8A495AFQ39064213-E75D0636-2463-4A5F-BD41-BB3753A94876Q39285766-DE3AC303-AE97-4BD1-8198-5E40C2F2C1E2Q39586865-47C43179-13A3-4038-A04E-C2CC15777CACQ39665695-B69309F1-31D7-4F28-B6E5-55809D21DB96Q39680398-2381D223-69C6-40AC-9028-E927E0CBF291Q39744026-91BD2F04-682A-4801-A04E-DA2EAA4861B3Q39943562-4CE0A04C-140A-4F09-ABB3-6F1C0E5442D4Q40003943-7D3F5863-C2CA-4A73-9CF5-03D795154A8FQ40071662-C599EE89-5DC3-4C9A-9283-BBF6DA46EA55Q40090775-5981F8E9-D5B4-4941-A822-FDBF166EF3ABQ40239635-E4D21E54-D902-49B9-B551-247115CE0CDFQ40344948-363AB642-28DA-47E1-8D6A-0606CBD3C608Q40477164-CD7DB713-00CE-424B-A398-441B3C9225B2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anders Woetmann
@ast
Anders Woetmann
@en
Anders Woetmann
@es
Anders Woetmann
@nl
type
label
Anders Woetmann
@ast
Anders Woetmann
@en
Anders Woetmann
@es
Anders Woetmann
@nl
prefLabel
Anders Woetmann
@ast
Anders Woetmann
@en
Anders Woetmann
@es
Anders Woetmann
@nl
P106
P21
P31
P496
0000-0002-3008-735X